Suchergebnisse - "Huang, Chung-Guei"

PubPharm (8)

1

Factors influencing neutralizing antibody titers elicited by coronavirus disease 2019 vaccines

enthalten in: Microbes and infection | 2023

von Kung, Y. | Huang, S. | Huang, C. | +13

2

Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19 : A single-blinded, randomized clinical trial

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022

von Chuang, C. | Huang, C. | Huang, C. | +10

3

A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19

enthalten in: Nature communications | 2022

von Chen, C. | Yang, L. | Chang, W. | +5

4

Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model

enthalten in: mSphere | 2022

von Liu, K. | Gong, Y. | Huang, C. | +22

5

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901 : interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan

enthalten in: The Lancet. Respiratory medicine | 2021

von Hsieh, S. | Liu, M. | Chen, Y. | +17

6

Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

enthalten in: PLoS pathogens | 2021

von Huang, K. | Tan, T. | Chen, T. | +22

ErratumIn: PLoS Pathog. 2021 Dec 10;17(12):e1010148. - PMID 34890427

7

Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19

enthalten in: Scientific reports | 2020

von Kuo, T. | Lin, M. | Coffman, R. | +11

8

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

enthalten in: Nature structural & molecular biology | 2020

von Zhou, D. | Duyvesteyn, H. | Chen, C. | +37

1
[1]